NASDAQ:POAI

Predictive Oncology (POAI) Stock Forecast, Price & News

$3.16

+0.04 (+1.28%)

(As of 09/26/2023 ET)

Compare

Today's Range: $3.05
▼
$3.21
50-Day Range: $2.96
▼
$6.21
52-Week Range: $2.47
▼
$13.88

Volume: 9,926 shs
Average Volume: 25,989 shs
Market Capitalization: $12.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Predictive Oncology (NASDAQ:POAI) Stock

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

POAI Price History

30 days | 90 days | 365 days | Advanced Chart

POAI Stock News Headlines

September 27, 2023 | americanbankingnews.com

Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below 200-Day Moving Average of $4.56

September 19, 2023 | americanbankingnews.com

Financial Review: Predictive Oncology (NASDAQ:POAI) vs. Opsens (OTCMKTS:OPSSF)

September 27, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.

August 12, 2023 | finance.yahoo.com

Predictive Oncology Inc. (NASDAQ:POAI) Q2 2023 Earnings Call Transcript

August 11, 2023 | finanznachrichten.de

Predictive Oncology Inc.: Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update

August 11, 2023 | finance.yahoo.com

Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update

August 3, 2023 | finance.yahoo.com

Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023

July 18, 2023 | proactiveinvestors.com

Predictive Oncology moves company headquarters to Pittsburgh

September 27, 2023 | Wall Street Fundamentals (Ad)

The "Plug and Play" Model Putting Online Giants to Shame

While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."

July 18, 2023 | finance.yahoo.com

Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh

June 29, 2023 | finance.yahoo.com

Is Predictive Oncology (NASDAQ:POAI) In A Good Position To Deliver On Growth Plans?

June 27, 2023 | proactiveinvestors.com

Predictive Oncology adds biopharmaceutical CFO Andrew Einhorn to business advisory board

June 27, 2023 | finance.yahoo.com

Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board

June 20, 2023 | finance.yahoo.com

Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board

May 23, 2023 | finance.yahoo.com

Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention

May 15, 2023 | finance.yahoo.com

Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update

May 10, 2023 | marketwatch.com

AI Tools are Enhancing Inclusivity and Reducing Bias in Hiring Processes

May 9, 2023 | finanznachrichten.de

FinancialBuzz.com: AI Tools are Enhancing Inclusivity and Reducing Bias in Hiring Processes

May 8, 2023 | finance.yahoo.com

Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023

May 3, 2023 | marketwatch.com

InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Appoints Seasoned Veteran as New Board Member

May 3, 2023 | proactiveinvestors.com

Predictive Oncology appoints healthcare commercial and business development veteran to its board

May 2, 2023 | finance.yahoo.com

Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors

April 21, 2023 | msn.com

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session

April 21, 2023 | msn.com

Why Predictive Oncology Stock Is Getting Hammered

April 21, 2023 | finanznachrichten.de

Predictive Oncology Inc.: Predictive Oncology Announces Reverse Stock Split

April 20, 2023 | finance.yahoo.com

Predictive Oncology Announces Reverse Stock Split

April 4, 2023 | finance.yahoo.com

Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board

See More Headlines

Receive POAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter.

POAI Company Calendar

Last Earnings: 8/10/2023
Today: 9/27/2023
Next Earnings (Estimated): 11/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:POAI
CUSIP: N/A
CIK: 1446159
Web: www.precisiontherapeutics.com
Phone: (651) 389-4800
Fax: N/A
Employees: 31
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($4.84)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-25,740,000.00
Net Margins: -1,246.52%
Pretax Margin: -1,246.52%
Return on Equity: -90.72%
Return on Assets: -73.16%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.24
Quick Ratio: 4.14

Sales & Book Value

Annual Sales: $1.51 million
Price / Sales: 8.43
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $5.53 per share
Price / Book: 0.57

Miscellaneous

Outstanding Shares: 4,030,000
Free Float: 3,937,000
Market Cap: $12.73 million
Optionable: Not Optionable
Beta: 1.54

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Raymond F. Vennare (Age 70)
CEO & Chairman
Comp: $581.58k

Mr. Robert L. Myers M.B.A. (Age 68)
CFO & Sec.
Comp: $511.87k

Ms. Theresa Ferguson
Sr. Director of Marketing

Dr. Pamela Bush M.B.A. (Age 49)
Ph.D., Chief Bus. Officer

Dr. Lawrence J. DeLucas D.Sc
O.D, Ph.D., Sr. VP of Biologics

Dr. Arlette H. Uihlein FCAP
M.D., Sr. VP of Translational Medicine & Drug Discovery and Medical Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

POAI Stock - Frequently Asked Questions

How have POAI shares performed in 2023?: Predictive Oncology's stock was trading at $6.1320 on January 1st, 2023. Since then, POAI stock has decreased by 48.5% and is now trading at $3.16.
View the best growth stocks for 2023 here.
When is Predictive Oncology's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our POAI earnings forecast.
How were Predictive Oncology's earnings last quarter?: Predictive Oncology Inc. (NASDAQ:POAI) released its quarterly earnings results on Thursday, August, 10th. The medical instruments supplier reported ($0.95) earnings per share for the quarter. The medical instruments supplier had revenue of $0.49 million for the quarter. Predictive Oncology had a negative net margin of 1,246.52% and a negative trailing twelve-month return on equity of 90.72%.
When did Predictive Oncology's stock split?: Predictive Oncology shares reverse split on the morning of Monday, April 24th 2023. The 1-20 reverse split was announced on Monday, April 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
What other stocks do shareholders of Predictive Oncology own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Predictive Oncology investors own include NVIDIA (NVDA), OPKO Health (OPK), Enphase Energy (ENPH), Inovio Pharmaceuticals (INO), Overstock.com (OSTK), Riot Platforms (RIOT), AcelRx Pharmaceuticals (ACRX), Boeing (BA), QUALCOMM (QCOM) and Sorrento Therapeutics (SRNE).

What is Predictive Oncology's stock symbol?: Predictive Oncology trades on the NASDAQ under the ticker symbol "POAI."
Who are Predictive Oncology's major shareholders?: Predictive Oncology's stock is owned by a variety of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.81%), RB Capital Management LLC (0.52%), Renaissance Technologies LLC (0.48%), State Street Corp (0.30%) and Carnegie Mellon University (0.26%). Insiders that own company stock include Carl I Schwartz, Charles Lee Sr Nuzum Sr, Daniel E Handley, J Melville Engle, Raymond F Vennare and Robert L Myers.
View institutional ownership trends.
How do I buy shares of Predictive Oncology?: Shares of POAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Predictive Oncology's stock price today?: One share of POAI stock can currently be purchased for approximately $3.16.
How much money does Predictive Oncology make?: Predictive Oncology (NASDAQ:POAI) has a market capitalization of $12.73 million and generates $1.51 million in revenue each year. The medical instruments supplier earns $-25,740,000.00 in net income (profit) each year or ($4.84) on an earnings per share basis.
How can I contact Predictive Oncology?: Predictive Oncology's mailing address is 2915 COMMERS DRIVE SUITE 900, EAGAN MN, 55121. The official website for the company is www.precisiontherapeutics.com. The medical instruments supplier can be reached via phone at (651) 389-4800 or via email at james@haydenir.com.

This page (NASDAQ:POAI) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial